The impacts of the diagnosis-related group payment reform on hospitalization-related medical expenses: evidence from China
DRG payment can control the growth of medical expenses and ease the burden on the medical insurance fund. However, the current rules may increase the OPP ratio and the economic burden on patients. A regulatory model in line with China's national conditions still must be explored.
Authors
- Wei Yang (ORCID: https://orcid.org/0000-0001-7249-4386)
- Lele Li (ORCID: https://orcid.org/0000-0003-0806-6680)
- Siyu Zeng (ORCID: https://orcid.org/0000-0001-7007-5647)
- Xiaofei Liu (ORCID: https://orcid.org/0000-0003-4379-4923)
- Siping Dong (ORCID: https://orcid.org/0000-0003-4661-7228)
- Xiaobin Tang (ORCID: https://orcid.org/0000-0003-3308-0468)
Institutions
- Chinese Center For Disease Control and Prevention (CN)
- Sichuan University (CN)
- Chengdu University of Information Technology (CN)
- National Institute of Hospital Administration (CN)
- Chengdu University (CN)
- Renmin University of China (CN)
Publication Details
- Journal
- Health Economics Review
- Published
- 2025-11-04
- DOI
- https://doi.org/10.1186/s13561-025-00687-8
- Citations
- 5
- Primary Topic
- Healthcare Systems and Reforms
- Type
- article
- Field-Weighted Citation Impact
- 11.04
Funders
- Chengdu University of Information Technology
- National Natural Science Foundation of China
- Chengdu University